Back to User profile » Dr Itasu Ninomiya

Papers published by Dr Itasu Ninomiya:


Peripheral Blood Platelet–Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients

Ohe Y, Fushida S, Yamaguchi T, Kinoshita J, Saito H, Okamoto K, Nakamura K, Tajima H, Ninomiya I, Ohta T

Cancer Management and Research 2020, 12:1303-1311

Published Date: 20 February 2020

Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy

Fushida S, Kinoshita J, Oyama K, Fujimura T, Tsukada T, Yamaguchi T, Ninomiya I, Ohta T

Cancer Management and Research 2018, 10:3833-3839

Published Date: 24 September 2018

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

Kurata T, Fushida S, Kinoshita J, Oyama K, Yamaguchi T, Okazaki M, Miyashita T, Tajima H, Ninomiya I, Ohta T

Cancer Management and Research 2018, 10:2729-2742

Published Date: 15 August 2018

The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance

Okazaki M, Fushida S, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Ninomiya I, Harada S, Ohta T

Cancer Management and Research 2018, 10:1865-1874

Published Date: 4 July 2018

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody

Fushida S, Oyama K, Kinoshita J, Yagi Y, Okamoto K, Tajima H, Ninomiya I, Fujimura T, Ohta T

OncoTargets and Therapy 2013, 6:1445-1451

Published Date: 16 October 2013